Truist Securities Maintains Buy on Intuitive Surgical, Raises Price Target to $390
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Richard Newitter has maintained a Buy rating on Intuitive Surgical (NASDAQ:ISRG) and increased the price target from $375 to $390.
December 22, 2023 | 2:54 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities analyst Richard Newitter has reaffirmed a Buy rating on Intuitive Surgical and raised the price target from $375 to $390.
The increase in price target by Truist Securities reflects a positive outlook on Intuitive Surgical's stock, suggesting potential upside. This could lead to increased investor confidence and a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100